Sandrine Marchand1,2,3, Salim Bouchene4, Michèle de Monte5, Laurent Guilleminault5, Jérôme Montharu5, Maria Cabrera5, Nicolas Grégoire6,7, Patrice Gobin6,8, Patrice Diot5, William Couet6,7,8, Laurent Vecellio5. 1. INSERM U-1070, Pôle Biologie Santé, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France. sandrine.marchand@univ-poitiers.fr. 2. Faculté de Médecine et de Pharmacie, Université de Poitiers, 6 rue de la Milétrie, 86073, Poitiers Cedex 9, France. sandrine.marchand@univ-poitiers.fr. 3. Laboratoire de Toxicologie et de Pharmacocinétique, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France. sandrine.marchand@univ-poitiers.fr. 4. Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden. 5. Centre d'Etude des Pathologies Respiratoires, INSERM UMR 1100/EA6305, Université de Tours, Faculté de Médecine, 10 Boulevard Tonnellé, 37032, Tours, France. 6. INSERM U-1070, Pôle Biologie Santé, 1 Rue Georges Bonnet, TSA 51106, 86073, Poitiers Cedex 9, France. 7. Faculté de Médecine et de Pharmacie, Université de Poitiers, 6 rue de la Milétrie, 86073, Poitiers Cedex 9, France. 8. Laboratoire de Toxicologie et de Pharmacocinétique, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France.
Abstract
PURPOSE: The objective of this study was to compare two different nebulizers: Eflow rapid® and Pari LC star® by scintigraphy and PK modeling to simulate epithelial lining fluid concentrations from measured plasma concentrations, after nebulization of CMS in baboons. METHODS: Three baboons received CMS by IV infusion and by 2 types of aerosols generators and colistin by subcutaneous infusion. Gamma imaging was performed after nebulisation to determine colistin distribution in lungs. Blood samples were collected during 9 h and colistin and CMS plasma concentrations were measured by LC-MS/MS. A population pharmacokinetic analysis was conducted and simulations were performed to predict lung concentrations after nebulization. RESULTS: Higher aerosol distribution into lungs was observed by scintigraphy, when CMS was nebulized with Pari LC® star than with Eflow Rapid® nebulizer. This observation was confirmed by the fraction of CMS deposited into the lung (respectively 3.5% versus 1.3%).CMS and colistin simulated concentrations in epithelial lining fluid were higher after using the Pari LC star® than the Eflow rapid® system. CONCLUSIONS: A limited fraction of CMS reaches lungs after nebulization, but higher colistin plasma concentrations were measured and higher intrapulmonary colistin concentrations were simulated with the Pari LC Star® than with the Eflow Rapid® system.
PURPOSE: The objective of this study was to compare two different nebulizers: Eflow rapid® and Pari LC star® by scintigraphy and PK modeling to simulate epithelial lining fluid concentrations from measured plasma concentrations, after nebulization of CMS in baboons. METHODS: Three baboons received CMS by IV infusion and by 2 types of aerosols generators and colistin by subcutaneous infusion. Gamma imaging was performed after nebulisation to determine colistin distribution in lungs. Blood samples were collected during 9 h and colistin and CMS plasma concentrations were measured by LC-MS/MS. A population pharmacokinetic analysis was conducted and simulations were performed to predict lung concentrations after nebulization. RESULTS: Higher aerosol distribution into lungs was observed by scintigraphy, when CMS was nebulized with Pari LC® star than with Eflow Rapid® nebulizer. This observation was confirmed by the fraction of CMS deposited into the lung (respectively 3.5% versus 1.3%).CMS and colistin simulated concentrations in epithelial lining fluid were higher after using the Pari LC star® than the Eflow rapid® system. CONCLUSIONS: A limited fraction of CMS reaches lungs after nebulization, but higher colistin plasma concentrations were measured and higher intrapulmonary colistin concentrations were simulated with the Pari LC Star® than with the Eflow Rapid® system.
Authors: Roger L Nation; Jian Li; Otto Cars; William Couet; Michael N Dudley; Keith S Kaye; Johan W Mouton; David L Paterson; Vincent H Tam; Ursula Theuretzbacher; Brian T Tsuji; John D Turnidge Journal: Clin Infect Dis Date: 2013-10-08 Impact factor: 9.079
Authors: I P Korbila; A Michalopoulos; P I Rafailidis; D Nikita; G Samonis; M E Falagas Journal: Clin Microbiol Infect Date: 2009-09-02 Impact factor: 8.067
Authors: Jean C Dubus; Laurent Vecellio; Michele De Monte; James B Fink; Daniel Grimbert; Jerome Montharu; Chantal Valat; Neil Behan; Patrice Diot Journal: Pediatr Res Date: 2005-03-17 Impact factor: 3.756
Authors: Rajesh V Dudhani; John D Turnidge; Kingsley Coulthard; Robert W Milne; Craig R Rayner; Jian Li; Roger L Nation Journal: Antimicrob Agents Chemother Date: 2009-12-22 Impact factor: 5.191
Authors: Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard Journal: J Antimicrob Chemother Date: 2004-03-24 Impact factor: 5.790
Authors: Cornelia B Landersdorfer; Tri-Hung Nguyen; Linh Thuy Lieu; Gary Nguyen; Robert J Bischof; Els N Meeusen; Jian Li; Roger L Nation; Michelle P McIntosh Journal: Antimicrob Agents Chemother Date: 2016-12-27 Impact factor: 5.191
Authors: Yu-Wei Lin; Qi Tony Zhou; Mei-Ling Han; Ke Chen; Nikolas J Onufrak; Jiping Wang; John D Turnidge; Benjamin P Howden; Alan Forrest; Hak-Kim Chan; Jian Li Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191